DPHARMA
Quarterly rpt on consolidated results for the financial period ended 31/3/2003
Amended Announcements
Please refer to the earlier announcement reference number: CU-030519-59145
| DUOPHARMA BIOTECH BHD |
|
Quarterly report for the financial period ended | 31/03/2003 |
| Quarter | 1 |
| Financial Year End | 31/12/2003 |
| The figures | have not been audited |
| Remarks : |
| Amendment was made to item A12 - Contingent Liabilities of the Notes to Interim Financial Report for the Quarterly Report on results for the period ended 31 March 2003. The amount for "Guarantees for banking facilities granted to its subsidiary" should be RM24,380,000 instead of RM20,180,000. |
SUMMARY OF KEY FINANCIAL INFORMATION31/03/2003 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/03/2003 | 31/03/2002 | 31/03/2003 | 31/03/2002 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
| 1 | Revenue | 19,513 | 0 | 19,513 | 0 |
| 2 | Profit/(loss) before tax | 6,035 | 0 | 6,035 | 0 |
| 3 | Profit/(loss) after tax and minority interest | 4,376 | 0 | 4,376 | 0 |
| 4 | Net profit/(loss) for the period | 4,376 | 0 | 4,376 | 0 |
| 5 | Basic earnings/(loss) per share (sen) | 8.75 | 0.00 | 8.75 | 0.00 |
| 6 | Dividend per share (sen) | 0.00 | 0.00 | 0.00 | 0.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
| 7 | Net tangible assets per share (RM) | 1.5800 | 1.5000 | ||
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Announcement Info
| Company Name | DUOPHARMA BIOTECH BHD |
| Stock Name | DBIOTEC |
| Date Announced | 27 May 2003 |
| Category | Financial Results |
| Reference No | CU-030527-60171 |